Birthmark removal may boost Kids' Well-Being, study hopes to prove

NCT ID NCT02280889

Recruiting now Symptom relief Sponsor: University Children's Hospital, Zurich Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at children with congenital melanocytic nevi (large birthmarks) who choose to have them surgically removed. Researchers want to see if removal improves quality of life and reduces feelings of being stigmatized. About 100 children aged 9 months to 16 years will be followed before and after surgery using questionnaires and interviews.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: surgical excision
What this could lead to: If successful, this study could provide evidence that surgical removal of congenital moles improves children's quality of life and reduces feelings of stigma.
What could go wrong: This is an observational study, not a treatment trial. Results may not apply to all children, and surgery carries risks like scarring or complications.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CONGENITAL MELANOCYTIC NEVI are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

large congenital melanocytic nevus melanocytic nevus severe cutaneous adverse reaction Stereotyping

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

QUALITY OF LIFE STIGMATIZATION

Contacts and locations

Locations

University Children's Hospital Zurich, Division of Pediatric Plastic and reconstructive Surgery
RECRUITING

Zurich, 8008, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.